D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
NGNE holding history
Neurogene Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NGNE overviewAll 13F holders of NGNEFull Q2 2026 holdings
- Shares (Q2 2026)
- 9,781
- Value
- $307.6K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 9,781 | $307.6K | <0.1% | +9,781 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −40,347−100.0% | Sold out | Holders |
| Q4 2025 | 40,347 | $831.1K | <0.1% | +40,347 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −196,421−100.0% | Sold out | Holders |
| Q2 2022 | 196,421 | $202.0K | <0.1% | +24,307+14.1% | Added | Holders |
| Q1 2022 | 172,114 | $324.0K | <0.1% | +108,799+171.8% | Added | Holders |
| Q4 2021 | 63,315 | $305.0K | <0.1% | +37,156+142.0% | Added | Holders |
| Q3 2021 | 26,159 | $189.0K | <0.1% | +26,159 | New | Holders |